nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—malignant glioma	0.577	1	CbGaD
Betamethasone—CYP3A4—Temozolomide—malignant glioma	0.033	1	CbGbCtD
Betamethasone—Monoplegia—Carmustine—malignant glioma	0.0133	0.0742	CcSEcCtD
Betamethasone—PLA2G1B—blood vessel—malignant glioma	0.0091	0.144	CbGeAlD
Betamethasone—Cushing's syndrome—Carmustine—malignant glioma	0.00904	0.0506	CcSEcCtD
Betamethasone—Conjunctival oedema—Carmustine—malignant glioma	0.00739	0.0414	CcSEcCtD
Betamethasone—Hyperaemia—Carmustine—malignant glioma	0.00679	0.038	CcSEcCtD
Betamethasone—Meningitis—Carmustine—malignant glioma	0.00529	0.0296	CcSEcCtD
Betamethasone—Opportunistic infection—Temozolomide—malignant glioma	0.00492	0.0275	CcSEcCtD
Betamethasone—Intracranial pressure increased—Carmustine—malignant glioma	0.00491	0.0275	CcSEcCtD
Betamethasone—Impaired healing—Carmustine—malignant glioma	0.00474	0.0265	CcSEcCtD
Betamethasone—PGR—blood vessel—malignant glioma	0.00419	0.0663	CbGeAlD
Betamethasone—Skin hyperpigmentation—Carmustine—malignant glioma	0.00345	0.0193	CcSEcCtD
Betamethasone—Visual acuity reduced—Temozolomide—malignant glioma	0.00333	0.0186	CcSEcCtD
Betamethasone—Embolism—Temozolomide—malignant glioma	0.00309	0.0173	CcSEcCtD
Betamethasone—Myopathy—Temozolomide—malignant glioma	0.00283	0.0158	CcSEcCtD
Betamethasone—Necrosis—Carmustine—malignant glioma	0.00261	0.0146	CcSEcCtD
Betamethasone—Abscess—Carmustine—malignant glioma	0.00259	0.0145	CcSEcCtD
Betamethasone—PLA2G1B—central nervous system—malignant glioma	0.00251	0.0397	CbGeAlD
Betamethasone—NR3C2—brainstem—malignant glioma	0.00246	0.039	CbGeAlD
Betamethasone—Petechiae—Temozolomide—malignant glioma	0.00241	0.0135	CcSEcCtD
Betamethasone—NR3C2—retina—malignant glioma	0.00238	0.0376	CbGeAlD
Betamethasone—Extravasation—Carmustine—malignant glioma	0.00235	0.0132	CcSEcCtD
Betamethasone—PTGS2—endothelium—malignant glioma	0.00227	0.0359	CbGeAlD
Betamethasone—Amenorrhoea—Temozolomide—malignant glioma	0.00226	0.0126	CcSEcCtD
Betamethasone—NR3C2—telencephalon—malignant glioma	0.00219	0.0346	CbGeAlD
Betamethasone—Leukocytosis—Carmustine—malignant glioma	0.00218	0.0122	CcSEcCtD
Betamethasone—Herpes simplex—Temozolomide—malignant glioma	0.00215	0.012	CcSEcCtD
Betamethasone—PTGS2—blood vessel—malignant glioma	0.00209	0.0331	CbGeAlD
Betamethasone—PLA2G1B—brain—malignant glioma	0.00199	0.0315	CbGeAlD
Betamethasone—Skin exfoliation—Carmustine—malignant glioma	0.00196	0.011	CcSEcCtD
Betamethasone—Neuropathy—Carmustine—malignant glioma	0.00193	0.0108	CcSEcCtD
Betamethasone—Skin exfoliation—Temozolomide—malignant glioma	0.00189	0.0106	CcSEcCtD
Betamethasone—Neuropathy—Temozolomide—malignant glioma	0.00186	0.0104	CcSEcCtD
Betamethasone—Dry eye—Temozolomide—malignant glioma	0.00183	0.0102	CcSEcCtD
Betamethasone—Thrombophlebitis—Carmustine—malignant glioma	0.00172	0.00963	CcSEcCtD
Betamethasone—NR3C2—medulla oblongata—malignant glioma	0.00172	0.0272	CbGeAlD
Betamethasone—Diabetes mellitus—Carmustine—malignant glioma	0.00171	0.00958	CcSEcCtD
Betamethasone—Thrombophlebitis—Temozolomide—malignant glioma	0.00166	0.0093	CcSEcCtD
Betamethasone—Eye pain—Carmustine—malignant glioma	0.00165	0.00923	CcSEcCtD
Betamethasone—Injury—Carmustine—malignant glioma	0.00162	0.00907	CcSEcCtD
Betamethasone—Eye pain—Temozolomide—malignant glioma	0.00159	0.00892	CcSEcCtD
Betamethasone—NR3C2—midbrain—malignant glioma	0.00157	0.0248	CbGeAlD
Betamethasone—NR3C2—spinal cord—malignant glioma	0.00153	0.0242	CbGeAlD
Betamethasone—NR3C1—embryo—malignant glioma	0.00144	0.0228	CbGeAlD
Betamethasone—Affect lability—Temozolomide—malignant glioma	0.00142	0.00793	CcSEcCtD
Betamethasone—Mood swings—Temozolomide—malignant glioma	0.00136	0.00763	CcSEcCtD
Betamethasone—Hypokalaemia—Carmustine—malignant glioma	0.00136	0.00758	CcSEcCtD
Betamethasone—NR3C1—brainstem—malignant glioma	0.00132	0.0209	CbGeAlD
Betamethasone—Dry skin—Temozolomide—malignant glioma	0.00132	0.00738	CcSEcCtD
Betamethasone—Muscular weakness—Carmustine—malignant glioma	0.00131	0.00735	CcSEcCtD
Betamethasone—Hypokalaemia—Temozolomide—malignant glioma	0.00131	0.00733	CcSEcCtD
Betamethasone—ABCB1—blood vessel—malignant glioma	0.00129	0.0205	CbGeAlD
Betamethasone—Muscular weakness—Temozolomide—malignant glioma	0.00127	0.0071	CcSEcCtD
Betamethasone—PTGS2—embryo—malignant glioma	0.00125	0.0197	CbGeAlD
Betamethasone—NR3C2—central nervous system—malignant glioma	0.00124	0.0197	CbGeAlD
Betamethasone—NR3C2—cerebellum—malignant glioma	0.00122	0.0192	CbGeAlD
Betamethasone—Sweating increased—Temozolomide—malignant glioma	0.00121	0.00678	CcSEcCtD
Betamethasone—NR3C1—telencephalon—malignant glioma	0.00117	0.0185	CbGeAlD
Betamethasone—Hyperglycaemia—Carmustine—malignant glioma	0.00116	0.0065	CcSEcCtD
Betamethasone—PGR—central nervous system—malignant glioma	0.00116	0.0183	CbGeAlD
Betamethasone—Weight increased—Temozolomide—malignant glioma	0.00113	0.00633	CcSEcCtD
Betamethasone—PGR—cerebellum—malignant glioma	0.00113	0.0179	CbGeAlD
Betamethasone—Weight decreased—Temozolomide—malignant glioma	0.00113	0.0063	CcSEcCtD
Betamethasone—Neuropathy peripheral—Carmustine—malignant glioma	0.00113	0.00629	CcSEcCtD
Betamethasone—Hyperglycaemia—Temozolomide—malignant glioma	0.00112	0.00628	CcSEcCtD
Betamethasone—Neuropathy peripheral—Temozolomide—malignant glioma	0.00109	0.00608	CcSEcCtD
Betamethasone—CYP19A1—central nervous system—malignant glioma	0.00104	0.0164	CbGeAlD
Betamethasone—Haemoglobin—Carmustine—malignant glioma	0.00104	0.00579	CcSEcCtD
Betamethasone—Haemorrhage—Carmustine—malignant glioma	0.00103	0.00576	CcSEcCtD
Betamethasone—Hallucination—Carmustine—malignant glioma	0.00103	0.00574	CcSEcCtD
Betamethasone—PTGS2—telencephalon—malignant glioma	0.00102	0.0161	CbGeAlD
Betamethasone—Haemoglobin—Temozolomide—malignant glioma	0.001	0.0056	CcSEcCtD
Betamethasone—Haemorrhage—Temozolomide—malignant glioma	0.000996	0.00557	CcSEcCtD
Betamethasone—Visual impairment—Carmustine—malignant glioma	0.000993	0.00556	CcSEcCtD
Betamethasone—Hallucination—Temozolomide—malignant glioma	0.000991	0.00554	CcSEcCtD
Betamethasone—NR3C2—brain—malignant glioma	0.000987	0.0156	CbGeAlD
Betamethasone—Eye disorder—Carmustine—malignant glioma	0.000963	0.00539	CcSEcCtD
Betamethasone—Visual impairment—Temozolomide—malignant glioma	0.00096	0.00537	CcSEcCtD
Betamethasone—Eye disorder—Temozolomide—malignant glioma	0.000931	0.00521	CcSEcCtD
Betamethasone—NR3C1—medulla oblongata—malignant glioma	0.000922	0.0146	CbGeAlD
Betamethasone—Arrhythmia—Carmustine—malignant glioma	0.000921	0.00515	CcSEcCtD
Betamethasone—PGR—brain—malignant glioma	0.000917	0.0145	CbGeAlD
Betamethasone—Alopecia—Carmustine—malignant glioma	0.000911	0.00509	CcSEcCtD
Betamethasone—Angiopathy—Temozolomide—malignant glioma	0.000903	0.00505	CcSEcCtD
Betamethasone—Erythema—Carmustine—malignant glioma	0.000897	0.00502	CcSEcCtD
Betamethasone—Alopecia—Temozolomide—malignant glioma	0.00088	0.00492	CcSEcCtD
Betamethasone—Erythema—Temozolomide—malignant glioma	0.000867	0.00485	CcSEcCtD
Betamethasone—NR3C1—midbrain—malignant glioma	0.000842	0.0133	CbGeAlD
Betamethasone—CYP19A1—brain—malignant glioma	0.000826	0.0131	CbGeAlD
Betamethasone—NR3C1—spinal cord—malignant glioma	0.000822	0.013	CbGeAlD
Betamethasone—Ill-defined disorder—Temozolomide—malignant glioma	0.000804	0.0045	CcSEcCtD
Betamethasone—PTGS2—medulla oblongata—malignant glioma	0.000798	0.0126	CbGeAlD
Betamethasone—Angioedema—Temozolomide—malignant glioma	0.000792	0.00443	CcSEcCtD
Betamethasone—Malaise—Temozolomide—malignant glioma	0.000782	0.00437	CcSEcCtD
Betamethasone—Vertigo—Temozolomide—malignant glioma	0.000779	0.00436	CcSEcCtD
Betamethasone—Convulsion—Carmustine—malignant glioma	0.000777	0.00435	CcSEcCtD
Betamethasone—Hypertension—Carmustine—malignant glioma	0.000774	0.00433	CcSEcCtD
Betamethasone—ABCB1—embryo—malignant glioma	0.000772	0.0122	CbGeAlD
Betamethasone—Myalgia—Carmustine—malignant glioma	0.000764	0.00427	CcSEcCtD
Betamethasone—Anxiety—Carmustine—malignant glioma	0.000761	0.00426	CcSEcCtD
Betamethasone—Convulsion—Temozolomide—malignant glioma	0.000751	0.0042	CcSEcCtD
Betamethasone—Hypertension—Temozolomide—malignant glioma	0.000748	0.00419	CcSEcCtD
Betamethasone—Myalgia—Temozolomide—malignant glioma	0.000738	0.00413	CcSEcCtD
Betamethasone—Anxiety—Temozolomide—malignant glioma	0.000735	0.00411	CcSEcCtD
Betamethasone—Oedema—Carmustine—malignant glioma	0.000732	0.0041	CcSEcCtD
Betamethasone—PTGS2—midbrain—malignant glioma	0.000729	0.0115	CbGeAlD
Betamethasone—Discomfort—Temozolomide—malignant glioma	0.000729	0.00408	CcSEcCtD
Betamethasone—Infection—Carmustine—malignant glioma	0.000727	0.00407	CcSEcCtD
Betamethasone—Thrombocytopenia—Carmustine—malignant glioma	0.000717	0.00401	CcSEcCtD
Betamethasone—Tachycardia—Carmustine—malignant glioma	0.000714	0.004	CcSEcCtD
Betamethasone—PTGS2—spinal cord—malignant glioma	0.000711	0.0112	CbGeAlD
Betamethasone—Anaphylactic shock—Temozolomide—malignant glioma	0.000707	0.00396	CcSEcCtD
Betamethasone—Oedema—Temozolomide—malignant glioma	0.000707	0.00396	CcSEcCtD
Betamethasone—Infection—Temozolomide—malignant glioma	0.000703	0.00393	CcSEcCtD
Betamethasone—Anorexia—Carmustine—malignant glioma	0.000698	0.0039	CcSEcCtD
Betamethasone—Nervous system disorder—Temozolomide—malignant glioma	0.000694	0.00388	CcSEcCtD
Betamethasone—Thrombocytopenia—Temozolomide—malignant glioma	0.000693	0.00387	CcSEcCtD
Betamethasone—Hypotension—Carmustine—malignant glioma	0.000684	0.00383	CcSEcCtD
Betamethasone—Hyperhidrosis—Temozolomide—malignant glioma	0.000684	0.00383	CcSEcCtD
Betamethasone—ABCB1—retina—malignant glioma	0.000683	0.0108	CbGeAlD
Betamethasone—Anorexia—Temozolomide—malignant glioma	0.000674	0.00377	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000667	0.00373	CcSEcCtD
Betamethasone—NR3C1—central nervous system—malignant glioma	0.000667	0.0105	CbGeAlD
Betamethasone—Insomnia—Carmustine—malignant glioma	0.000662	0.0037	CcSEcCtD
Betamethasone—Paraesthesia—Carmustine—malignant glioma	0.000657	0.00368	CcSEcCtD
Betamethasone—NR3C1—cerebellum—malignant glioma	0.000652	0.0103	CbGeAlD
Betamethasone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000645	0.00361	CcSEcCtD
Betamethasone—Insomnia—Temozolomide—malignant glioma	0.00064	0.00358	CcSEcCtD
Betamethasone—Decreased appetite—Carmustine—malignant glioma	0.000636	0.00356	CcSEcCtD
Betamethasone—Paraesthesia—Temozolomide—malignant glioma	0.000635	0.00355	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000632	0.00354	CcSEcCtD
Betamethasone—ABCB1—telencephalon—malignant glioma	0.000628	0.00993	CbGeAlD
Betamethasone—Pain—Carmustine—malignant glioma	0.000626	0.0035	CcSEcCtD
Betamethasone—Dyspepsia—Temozolomide—malignant glioma	0.000623	0.00348	CcSEcCtD
Betamethasone—Decreased appetite—Temozolomide—malignant glioma	0.000615	0.00344	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000611	0.00342	CcSEcCtD
Betamethasone—Fatigue—Temozolomide—malignant glioma	0.00061	0.00341	CcSEcCtD
Betamethasone—Pain—Temozolomide—malignant glioma	0.000605	0.00338	CcSEcCtD
Betamethasone—Feeling abnormal—Carmustine—malignant glioma	0.000603	0.00337	CcSEcCtD
Betamethasone—Gastrointestinal pain—Carmustine—malignant glioma	0.000599	0.00335	CcSEcCtD
Betamethasone—Feeling abnormal—Temozolomide—malignant glioma	0.000583	0.00326	CcSEcCtD
Betamethasone—Abdominal pain—Carmustine—malignant glioma	0.000579	0.00324	CcSEcCtD
Betamethasone—Body temperature increased—Carmustine—malignant glioma	0.000579	0.00324	CcSEcCtD
Betamethasone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000578	0.00324	CcSEcCtD
Betamethasone—PTGS2—central nervous system—malignant glioma	0.000577	0.00912	CbGeAlD
Betamethasone—PTGS2—cerebellum—malignant glioma	0.000564	0.00892	CbGeAlD
Betamethasone—Urticaria—Temozolomide—malignant glioma	0.000562	0.00314	CcSEcCtD
Betamethasone—Body temperature increased—Temozolomide—malignant glioma	0.000559	0.00313	CcSEcCtD
Betamethasone—Abdominal pain—Temozolomide—malignant glioma	0.000559	0.00313	CcSEcCtD
Betamethasone—NR3C1—brain—malignant glioma	0.000529	0.00837	CbGeAlD
Betamethasone—Asthenia—Carmustine—malignant glioma	0.000525	0.00294	CcSEcCtD
Betamethasone—Asthenia—Temozolomide—malignant glioma	0.000508	0.00284	CcSEcCtD
Betamethasone—CYP3A4—central nervous system—malignant glioma	0.000504	0.00797	CbGeAlD
Betamethasone—Diarrhoea—Carmustine—malignant glioma	0.000501	0.0028	CcSEcCtD
Betamethasone—Pruritus—Temozolomide—malignant glioma	0.000501	0.0028	CcSEcCtD
Betamethasone—ABCB1—medulla oblongata—malignant glioma	0.000493	0.0078	CbGeAlD
Betamethasone—Dizziness—Carmustine—malignant glioma	0.000484	0.00271	CcSEcCtD
Betamethasone—Diarrhoea—Temozolomide—malignant glioma	0.000484	0.00271	CcSEcCtD
Betamethasone—Dizziness—Temozolomide—malignant glioma	0.000468	0.00262	CcSEcCtD
Betamethasone—Vomiting—Carmustine—malignant glioma	0.000465	0.0026	CcSEcCtD
Betamethasone—Rash—Carmustine—malignant glioma	0.000462	0.00258	CcSEcCtD
Betamethasone—Dermatitis—Carmustine—malignant glioma	0.000461	0.00258	CcSEcCtD
Betamethasone—Headache—Carmustine—malignant glioma	0.000459	0.00257	CcSEcCtD
Betamethasone—PTGS2—brain—malignant glioma	0.000458	0.00724	CbGeAlD
Betamethasone—ABCB1—midbrain—malignant glioma	0.000451	0.00713	CbGeAlD
Betamethasone—Vomiting—Temozolomide—malignant glioma	0.00045	0.00252	CcSEcCtD
Betamethasone—Rash—Temozolomide—malignant glioma	0.000446	0.0025	CcSEcCtD
Betamethasone—Dermatitis—Temozolomide—malignant glioma	0.000446	0.00249	CcSEcCtD
Betamethasone—Headache—Temozolomide—malignant glioma	0.000443	0.00248	CcSEcCtD
Betamethasone—ABCB1—spinal cord—malignant glioma	0.00044	0.00696	CbGeAlD
Betamethasone—Nausea—Carmustine—malignant glioma	0.000435	0.00243	CcSEcCtD
Betamethasone—Nausea—Temozolomide—malignant glioma	0.00042	0.00235	CcSEcCtD
Betamethasone—ABCB1—central nervous system—malignant glioma	0.000357	0.00564	CbGeAlD
Betamethasone—ABCB1—cerebellum—malignant glioma	0.000349	0.00552	CbGeAlD
Betamethasone—ABCB1—brain—malignant glioma	0.000283	0.00448	CbGeAlD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	6.2e-05	0.00042	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.2e-05	0.00042	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—YWHAE—malignant glioma	6.06e-05	0.00041	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK2—malignant glioma	6.06e-05	0.00041	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	6.06e-05	0.00041	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CD—malignant glioma	6.05e-05	0.00041	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FLT1—malignant glioma	6.04e-05	0.000409	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—DUSP6—malignant glioma	6.01e-05	0.000407	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—malignant glioma	6e-05	0.000406	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.98e-05	0.000405	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JAG1—malignant glioma	5.93e-05	0.000402	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—COX8A—malignant glioma	5.93e-05	0.000401	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH3—malignant glioma	5.91e-05	0.0004	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FBXW7—malignant glioma	5.81e-05	0.000393	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	5.72e-05	0.000387	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	5.72e-05	0.000387	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BDKRB2—malignant glioma	5.7e-05	0.000386	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEY2—malignant glioma	5.67e-05	0.000383	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.65e-05	0.000382	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—malignant glioma	5.64e-05	0.000382	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—H3F3A—malignant glioma	5.59e-05	0.000379	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IDH1—malignant glioma	5.53e-05	0.000375	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.45e-05	0.000369	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.4e-05	0.000366	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	5.39e-05	0.000365	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—IDH2—malignant glioma	5.39e-05	0.000365	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTT1—malignant glioma	5.32e-05	0.00036	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH2—malignant glioma	5.3e-05	0.000359	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CB—malignant glioma	5.28e-05	0.000357	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH3—malignant glioma	5.25e-05	0.000356	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HEY1—malignant glioma	5.25e-05	0.000355	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—malignant glioma	5.23e-05	0.000354	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KNG1—malignant glioma	5.19e-05	0.000351	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.12e-05	0.000347	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIST1H3B—malignant glioma	5.1e-05	0.000345	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.08e-05	0.000344	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2B6—malignant glioma	5.07e-05	0.000343	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH1—malignant glioma	5.04e-05	0.000341	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.04e-05	0.000341	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ASMT—malignant glioma	5.04e-05	0.000341	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	5.04e-05	0.000341	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.03e-05	0.00034	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS1—malignant glioma	4.98e-05	0.000337	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.97e-05	0.000337	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.97e-05	0.000337	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.96e-05	0.000336	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NTRK1—malignant glioma	4.94e-05	0.000335	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	4.86e-05	0.000329	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.86e-05	0.000329	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—malignant glioma	4.76e-05	0.000322	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCAN—malignant glioma	4.74e-05	0.000321	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH2—malignant glioma	4.71e-05	0.000319	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAG2—malignant glioma	4.65e-05	0.000315	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—IDH1—malignant glioma	4.63e-05	0.000314	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BCHE—malignant glioma	4.63e-05	0.000314	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.63e-05	0.000314	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.63e-05	0.000313	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP3—malignant glioma	4.59e-05	0.000311	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.59e-05	0.000311	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—malignant glioma	4.58e-05	0.00031	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—malignant glioma	4.56e-05	0.000309	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—malignant glioma	4.55e-05	0.000308	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	4.51e-05	0.000306	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SPHK1—malignant glioma	4.48e-05	0.000304	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—malignant glioma	4.46e-05	0.000302	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTK2—malignant glioma	4.42e-05	0.000299	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.4e-05	0.000298	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP2C18—malignant glioma	4.39e-05	0.000297	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HES1—malignant glioma	4.34e-05	0.000294	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.33e-05	0.000293	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NCOR1—malignant glioma	4.32e-05	0.000292	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.29e-05	0.00029	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.24e-05	0.000287	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.22e-05	0.000286	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.14e-05	0.00028	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDGFRA—malignant glioma	4.14e-05	0.00028	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	4.08e-05	0.000276	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—malignant glioma	4.05e-05	0.000274	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—malignant glioma	4.02e-05	0.000272	CbGpPWpGaD
Betamethasone—PTGS2—Disease—H3F3A—malignant glioma	3.94e-05	0.000266	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NCOR1—malignant glioma	3.84e-05	0.00026	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.83e-05	0.000259	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IDH2—malignant glioma	3.82e-05	0.000259	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TERT—malignant glioma	3.81e-05	0.000258	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.77e-05	0.000255	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.74e-05	0.000253	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDGFB—malignant glioma	3.72e-05	0.000252	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JAG1—malignant glioma	3.71e-05	0.000251	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGFR1—malignant glioma	3.7e-05	0.00025	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTP1—malignant glioma	3.69e-05	0.000249	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—COX8A—malignant glioma	3.65e-05	0.000247	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.64e-05	0.000247	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—malignant glioma	3.64e-05	0.000246	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FBXW7—malignant glioma	3.64e-05	0.000246	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2B6—malignant glioma	3.59e-05	0.000243	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAT—malignant glioma	3.59e-05	0.000243	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTT1—malignant glioma	3.55e-05	0.00024	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.52e-05	0.000239	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CAV1—malignant glioma	3.52e-05	0.000238	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—malignant glioma	3.48e-05	0.000236	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.45e-05	0.000233	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.45e-05	0.000233	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NCOR1—malignant glioma	3.39e-05	0.000229	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—F2—malignant glioma	3.35e-05	0.000227	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FN1—malignant glioma	3.35e-05	0.000227	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTGS1—malignant glioma	3.33e-05	0.000225	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.32e-05	0.000225	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BAD—malignant glioma	3.31e-05	0.000224	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—IDH1—malignant glioma	3.28e-05	0.000222	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.28e-05	0.000222	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—malignant glioma	3.28e-05	0.000222	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	3.26e-05	0.000221	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.26e-05	0.00022	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—malignant glioma	3.22e-05	0.000218	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CD80—malignant glioma	3.21e-05	0.000218	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CG—malignant glioma	3.21e-05	0.000217	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—malignant glioma	3.21e-05	0.000217	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SPHK1—malignant glioma	3.18e-05	0.000215	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGF—malignant glioma	3.17e-05	0.000215	CbGpPWpGaD
Betamethasone—Triamcinolone—BCHE—malignant glioma	3.16e-05	0.442	CrCbGaD
Betamethasone—PGR—Signaling Pathways—PTPN11—malignant glioma	3.15e-05	0.000213	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP2C18—malignant glioma	3.11e-05	0.000211	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ASMT—malignant glioma	3.11e-05	0.00021	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BCHE—malignant glioma	3.1e-05	0.00021	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—malignant glioma	3.09e-05	0.000209	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—malignant glioma	3.06e-05	0.000207	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—malignant glioma	3.01e-05	0.000204	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.99e-05	0.000203	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT2—malignant glioma	2.93e-05	0.000199	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCAN—malignant glioma	2.92e-05	0.000198	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—malignant glioma	2.92e-05	0.000197	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.89e-05	0.000196	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.89e-05	0.000196	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—malignant glioma	2.85e-05	0.000193	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CD—malignant glioma	2.82e-05	0.000191	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CAV1—malignant glioma	2.76e-05	0.000187	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—malignant glioma	2.75e-05	0.000186	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HES1—malignant glioma	2.72e-05	0.000184	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—malignant glioma	2.71e-05	0.000184	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NCOR1—malignant glioma	2.7e-05	0.000183	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF2—malignant glioma	2.7e-05	0.000183	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.64e-05	0.000179	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—malignant glioma	2.63e-05	0.000178	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFRA—malignant glioma	2.59e-05	0.000175	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MDM2—malignant glioma	2.53e-05	0.000171	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—malignant glioma	2.52e-05	0.00017	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAF1—malignant glioma	2.52e-05	0.00017	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CG—malignant glioma	2.51e-05	0.00017	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.5e-05	0.000169	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—malignant glioma	2.49e-05	0.000169	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—malignant glioma	2.46e-05	0.000167	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CB—malignant glioma	2.46e-05	0.000166	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.44e-05	0.000165	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—malignant glioma	2.43e-05	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CAT—malignant glioma	2.4e-05	0.000162	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HLA-A—malignant glioma	2.38e-05	0.000161	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TERT—malignant glioma	2.38e-05	0.000161	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—malignant glioma	2.36e-05	0.00016	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS1—malignant glioma	2.36e-05	0.00016	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH2—malignant glioma	2.35e-05	0.000159	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PDGFB—malignant glioma	2.32e-05	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGFR1—malignant glioma	2.31e-05	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—malignant glioma	2.28e-05	0.000154	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NCOR1—malignant glioma	2.26e-05	0.000153	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CASP3—malignant glioma	2.26e-05	0.000153	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—malignant glioma	2.26e-05	0.000153	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.21e-05	0.00015	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CD—malignant glioma	2.21e-05	0.00015	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CAV1—malignant glioma	2.2e-05	0.000149	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCHE—malignant glioma	2.19e-05	0.000149	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—malignant glioma	2.17e-05	0.000147	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—malignant glioma	2.14e-05	0.000145	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—malignant glioma	2.12e-05	0.000144	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BAD—malignant glioma	2.07e-05	0.00014	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—malignant glioma	2.05e-05	0.000139	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—IDH1—malignant glioma	2.02e-05	0.000137	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD80—malignant glioma	2.01e-05	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—malignant glioma	2.01e-05	0.000136	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2e-05	0.000135	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGF—malignant glioma	1.98e-05	0.000134	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTPN11—malignant glioma	1.97e-05	0.000133	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.96e-05	0.000133	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CB—malignant glioma	1.93e-05	0.00013	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.92e-05	0.00013	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—malignant glioma	1.92e-05	0.00013	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—malignant glioma	1.91e-05	0.000129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—malignant glioma	1.9e-05	0.000129	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—malignant glioma	1.89e-05	0.000128	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—malignant glioma	1.88e-05	0.000127	CbGpPWpGaD
Betamethasone—Dexamethasone—CYP2B6—malignant glioma	1.85e-05	0.258	CrCbGaD
Betamethasone—PTGS2—Metabolism—CAV1—malignant glioma	1.84e-05	0.000125	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT2—malignant glioma	1.84e-05	0.000124	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—malignant glioma	1.76e-05	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CD—malignant glioma	1.76e-05	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.76e-05	0.000119	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—malignant glioma	1.75e-05	0.000118	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—malignant glioma	1.73e-05	0.000117	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAT—malignant glioma	1.7e-05	0.000115	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF2—malignant glioma	1.69e-05	0.000114	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CG—malignant glioma	1.68e-05	0.000114	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—malignant glioma	1.67e-05	0.000113	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—malignant glioma	1.63e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—malignant glioma	1.62e-05	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOR1—malignant glioma	1.6e-05	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MDM2—malignant glioma	1.58e-05	0.000107	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAF1—malignant glioma	1.57e-05	0.000107	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—malignant glioma	1.57e-05	0.000106	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—malignant glioma	1.56e-05	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—malignant glioma	1.55e-05	0.000105	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CB—malignant glioma	1.54e-05	0.000104	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—malignant glioma	1.5e-05	0.000101	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CD—malignant glioma	1.48e-05	0.0001	CbGpPWpGaD
Betamethasone—Triamcinolone—PTGS2—malignant glioma	1.46e-05	0.204	CrCbGaD
Betamethasone—CYP3A4—Metabolism—PTGS1—malignant glioma	1.45e-05	9.84e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—malignant glioma	1.45e-05	9.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCHE—malignant glioma	1.35e-05	9.15e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.34e-05	9.04e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—malignant glioma	1.33e-05	8.99e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CAV1—malignant glioma	1.31e-05	8.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CB—malignant glioma	1.29e-05	8.72e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—malignant glioma	1.22e-05	8.29e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CG—malignant glioma	1.19e-05	8.06e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—malignant glioma	1.19e-05	8.04e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—malignant glioma	1.17e-05	7.95e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—malignant glioma	1.15e-05	7.78e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—malignant glioma	1.11e-05	7.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—malignant glioma	1.1e-05	7.47e-05	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—malignant glioma	1.09e-05	7.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—malignant glioma	1.08e-05	7.31e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—malignant glioma	1.08e-05	7.28e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CD—malignant glioma	1.05e-05	7.09e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAT—malignant glioma	1.05e-05	7.08e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—malignant glioma	1.02e-05	6.91e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOR1—malignant glioma	9.88e-06	6.69e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—malignant glioma	9.6e-06	6.5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—malignant glioma	9.37e-06	6.34e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CB—malignant glioma	9.13e-06	6.18e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—malignant glioma	9.04e-06	6.12e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CAV1—malignant glioma	8.06e-06	5.45e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—malignant glioma	7.89e-06	5.34e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—malignant glioma	7.85e-06	5.31e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—malignant glioma	7.66e-06	5.18e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CG—malignant glioma	7.34e-06	4.97e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—malignant glioma	7.08e-06	4.79e-05	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—malignant glioma	6.95e-06	0.097	CrCbGaD
Betamethasone—CYP3A4—Metabolism—PIK3CD—malignant glioma	6.45e-06	4.37e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—malignant glioma	6.41e-06	4.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CB—malignant glioma	5.62e-06	3.81e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—malignant glioma	5.57e-06	3.77e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—malignant glioma	5.56e-06	3.77e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—malignant glioma	4.86e-06	3.29e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—malignant glioma	4.55e-06	3.08e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—malignant glioma	3.43e-06	2.32e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—malignant glioma	2.8e-06	1.9e-05	CbGpPWpGaD
